Literature DB >> 8910897

Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.

P A Lapchak1, P J Miller, S Jiao, D M Araujo, D Hilt, F Collins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910897     DOI: 10.1006/neur.1996.0027

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


× No keyword cloud information.
  6 in total

Review 1.  Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.

Authors:  D S Latchman
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

2.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures.

Authors:  Javier Vargas-Medrano; Ismael Segura-Ulate; Barbara Yang; Ramesh Chinnasamy; Jeffrey B Arterburn; Ruth G Perez
Journal:  Neuropharmacology       Date:  2019-07-07       Impact factor: 5.250

Review 4.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

5.  Anesthesia implications in emergency oncologic surgery in a case of untreated Parkinsonism.

Authors:  Sukhwinder Kaur Bajwa; Sukhminder Jit Singh Bajwa; Jasbir Kaur; Anita Singh
Journal:  Saudi J Anaesth       Date:  2011-07

6.  The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells.

Authors:  M J Tang; D Worley; M Sanicola; G R Dressler
Journal:  J Cell Biol       Date:  1998-09-07       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.